Transaction DateRecipientSharesTypePriceValue
11th August 2020Chaitan Phd Khosla2,499Open or private sale$17.19$42,952.06
11th August 2020Chaitan Phd Khosla2,499Exercise of derivative$1.89$4,723.11
23rd June 2020Bryan Giraudo2,000Open or private purchase$12.96$25,922.40
29th April 2020Dinesh V Ph D Patel2,000Bona fide gift$0.00
20th March 2020Dinesh V Ph D Patel10,000Exercise of derivative$1.89$18,900.00
12th March 2020Dinesh V Ph D Patel18,344Exercise of derivative$1.16$21,279.04
12th March 2020Harold E Selick12,000Open or private purchase$6.70$80,400.00
14th February 2020Bryan Giraudo46,500Grant/award etc.$0.00
3rd December 2019Dinesh V Ph D Patel10,000Open or private purchase$5.55$55,500.00
3rd December 2019Dinesh V Ph D Patel20,000Open or private purchase$5.65$113,000.00
Protagonist Therapeutics
Protagonist Therapeutics logo

Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The firm's initial lead product candidates are being developed for moderate-to-severe ulcerative colitis and Crohn's disease.


Ticker: PTGX
Sector: Healthcare
Industry: Biotechnology
SEC Central Index Key (CIK): 1377121
Employees: 64
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals